In the difficult and extraordinary
times of a Coronavirus pandemic, Bio-Check
(UK) would like to reassure its customers, staff, suppliers and other stakeholders that we are
continually reviewing – in line with WHO, NHS and UK
Government advice –
and escalating the measures we take to mitigate the adverse impact
of the effects of the virus.
The UK Coronavirus Act 2020, which received Royal Assent on
25th March, provides the UK Government with the emergency powers it
needs to tackle the further spread of the virus. In this Act, the key workers list includes all those who are
involved with the provision of key goods necessary for the manufacture and supply of food. Bio-Check (UK) is
naturally pleased to play its part, ensuring that its food testing kits (e.g.
for detection of gluten, food allergens, mycotoxins) continue to be available
to help food manufacturers provide all of us – especially the vulnerable – with safe
food of the stated quality.
We urge all
existing and potential users of our test kits to discuss their changing requirements with us over the
course of this outbreak;
by doing so,
Bio-Check can better ensure the continuity of
supplies for all.
If you need more
information about our products and the stocks available, please contact us email@example.com.
By heeding the medical and behavioural (social distancing) advice being provided by the NHS and UK Government, you, your colleagues, families, friends and neighbours will have the best chance of keeping safe and well.
Contract Manufacture of LFDs
Bio-Check (UK) develops and
manufactures a range of rapid “on-site/point of care” tests (lateral flow
devices) including for the detection of disease antibodies in blood. We have an
on-farm test for antibodies to cattle/sheep liver flukes and, more pertinently,
several tests to detect very low levels of human (IgE) antibodies indicative of
allergic/anaphylactic reactions. Importantly, we manufacture device components
that are CE marked for home use as well as doctors; the device uses tiny
quantities of whole, finger-prick blood, removes the problem of “prozoning”
(high dose hook; overloading) by non-specific antibodies; test results are
available in a few minutes. Bio-Check’s management team has many decades of
experience in the fields of in vitro diagnostic testing for medical diagnostics
and research, pharmaceutical analysis and food testing applications. Our
Quality Management System is ISO9001:2015 certified.
This information is compiled from online sources accessed on 31-March-2020:
A new strain of virus is causing Severe Acute Respiratory Syndrome (SARS) in humans. The new SARS coronavirus (SARS-CoV), called SARS-CoV-2, from the Coronaviridae family of viruses that primarily infect birds and mammals, is a positive-strand RNA virus. It was first discovered in December 2019 in Wuhan, Hubei Province of China, and sequenced and isolated in January 2020. The resulting outbreak of SARS-CoV-2 has caused the coronavirus infectious disease 2019 (COVID-19). SARS-CoV-2 is not the same as an influenza virus, it belongs to a different family of RNA viruses. COVID-19 and influenza, both cause respiratory illnesses spread from person to person through tiny droplets containing the virus, during exhalation and in coughs and sneezes. The symptoms of the diseases have some important differences, including that SARS-CoV-2 spreads and potentially kills more readily. Globally, it has spread to be a pandemic (WHO, 11 March 2020). Unlike many respiratory viruses, it seems to infect both the upper and lower respiratory tract.
Food has not been identified as a
likely source or route of transmission of the virus according to EFSA. The
virus is spread through direct contact with respiratory droplets from an
infected person, as described above. Furthermore, it is believed that the virus
is sensitive to heat and that the typical temperature and time regimes of
cooking to ensure food safety are sufficient to inactive the virus and reduce
Each spherical SARS-CoV-2 virus
particle (about 80-90nm in size) consists of the RNA genome enclosed by a viral
envelope, a lipid bilayer with structural proteins, including glycoprotein
spikes that protrude from the particle surface to form a ‘corona’ or crown of
spikes. The coronavirus spikes are known to play a key role in how it infects
the host human cell. The viral envelope protects the virus when outside the
host cell in the environment.
With aerial (direct) and surface
(indirect) transmission of the SARS-CoV-2 virus, the stability of SARS-CoV-2 has been reported by the New England
Journal of Medicine to be more stable on plastic and stainless steel than on
cardboard, and viable virus was detected up to 72 hours after application to
these surface, although the virus titre was greatly reduced. On cardboard, no
viable SARS-CoV-2 was measured after 24 hours. Results indicate that aerosol
and indirect transmission by contaminated objects is plausible, since the virus
can remain viable and infectious in aerosols for hours and on surfaces up to
days (depending on the inoculum shed).
Although it is unlikely that SARS-CoV-2 is spread by contaminated food it is advisable to ensure social distancing in a food plant together with robust personal (e.g. frequent handwashing and not touching the face) and food safety hygiene during food preparation to prevent cross-contamination (e.g. by handling and objects) and to heat food to reduce the risk when appropriate. Washing hands is believed to be effective at inactivating the virus, because the soap or liquid detergent disrupts the lipid bilayer of the SARS-CoV-2 causing the virus particle to disintegrate and be easily rinsed away. Although there have been no studies on the effectiveness of formulated disinfectants against SARS-CoV-2 on food contact surfaces (following the important detergent cleaning and rinsing stages), those with an oxidising nature such as hypochlorite, peracetic acid and hydrogen peroxide are likely to be effective at an appropriate working concentration (please discuss with your cleaning chemical supplier).
Recently developed analytical methods for detecting SARS-CoV-2 in food and on food surfaces typically target at least two genes in the virus genome (e.g. coding for the envelope or the nucleocapsid). Following sampling and RNA extraction a sensitive Real-Time RT-PCR technique is employed for detection.
Please refer to the latest official
guidance and peer reviewed references when formulating policy, practices and
procedures on mitigating the risks posed by COVID-19. Some helpful references
and hyperlinks are listed below:
Van Doremalen et al., (2020) Aerosol
and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 The New England
Journal of Medicine, Letter to the Editor 17 March 2020 https://doi.org/10.1056/NEJMc2004973
In the difficult and extraordinary times of a Coronavirus pandemic, Bio-Check (UK) would like to reassure its customers, staff, suppliers and other stakeholders that we are continually reviewing – in line with WHO, NHS and UK Government advice – and escalating the measures we take to mitigate the adverse impact developing as a result of the effects of the virus.
The UK Coronavirus Bill,
which was announced on 18 March, will provide the UK Government with the
emergency powers it needs to tackle the further spread of the virus. In this
proposed bill, the key workers list includes all those who are involved with the provision
of key goods necessary for the manufacture and
supply of food. Bio-Check (UK) is naturally
pleased to play its part, to ensure that its food testing kits (e.g. for
detection of gluten, food allergens, mycotoxins) continue to be available to help food manufacturers
of us – especially the vulnerable – safe food of the stated quality.
We urge all existing and
potential users of our test kits to discuss their changing requirements
with us over the course of this outbreak; by doing so, Bio-Check can better
ensure the continuity of supplies for all.
If you need more information
about our products and the stocks available, please contact us firstname.lastname@example.org.
By heeding the medical and behavioural advice
being provided by the NHS and UK Government, you, your colleagues, families, friends and neighbours will have the best chance of keeping safe and well.
Certification for issue 8 of the BRC Global Standard Food Safety starts from 1st February 2019. There are several new requirements (e.g. 1.1.2 food safety and quality culture plan) and a couple of new sections (e.g. section 8 production risk zones). Food Safety professionals are making improvements to satisfy the requirements of the standard and reviewing what objective evidence they can provide to support these requirements. This evidence will be needed for the third-party audit(s) and for internal audits which now need to be spread throughout the year with a minimum of 4 different dates (3.4.1). Sampling and testing will provide an important portion of the objective evidence necessary included in, for example: the Management of suppliers of raw materials (3.5.1), Traceability (3.9), Food Defence (4.2), Housekeeping and hygiene (4.11), Environmental monitoring (4.11.8), Management of Food Allergens (5.3) and Product Authenticity (5.4). There is also a new requirement (188.8.131.52) that the significance of laboratory results should be understood and acted upon accordingly. All these changes are making the role of sampling and analysis more important, yet increasingly complex to understand especially with the new analytical technology. For example, recent advances in onsite testing and ‘next-generation’ sequencing are driving a paradigm shift towards increasing use of such tests to improve control and decision making in food manufacture.
Related products:onsite Allergen, Gluten and Raw Meat Species FlowThrough™ tests.
Parliament has decreed that the United Kingdom will leave the European Union on the 29th of March 2019.
Whilst the details surrounding the process are currently unclear, the impending departure will mean changes for us all.
Although Bio-Check (UK) develops and manufactures its products in the UK, we do obtain some supplies from overseas. Given the potential for customs checks to cause delays, we are temporarily increasing our stocks as a contingency.
If you intend to do the same with stocks of Bio-Check’s food testing kits, please do let us know without delay, so that we can make it possible to provide all our customers in these uncertain times.
As I am sure you are aware, from 25th May the EU General Data Protection Regulation (2016/679; GDPR) gives you greater protection, rights and control over how your data is used. In response to this Regulation, Bio-Check (UK) would like to let you know how we are storing and using your data.
You do not need to do anything, other than read the information below.
Hold your data (e.g. contact details, purchasing history, product interests etc) securely.
Contact you when we believe there is a legitimate interest to do so (e.g. follow-up to orders and enquiries, updates to new products & services etc).
Not share your data with third parties. unless it is to fulfil services you have requested (e.g. provide shipping instructions to couriers).
If required, analyse your data to understand how we can continuously improve our services to you (e.g. in the context of customer satisfaction under our IS09001 accreditation).
Respect your preferences in respect of communications (e.g. remove you from our mailing list).
You can decide to stop us contacting you at any time, or ask us to amend your preferences, simply by informing us via email@example.com.